Illumina

Global Proteomic Biomarker Analytics Market Analysis Report 2024 with Executive & Consultant Guides; Including Customized Forecasting and Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, March 29, 2024
Health, Biotechnology, Illumina, Assay, Place, Proteomics, Genomics, Research, Cancer, Application

The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Where genomics couldn't find all the answers proteomics is stepping up to the plate.
  • Proteomic Biomarker Analytics is just finding its feet, but the opportunity is to understand the front line players, the actual proteins and protein complexes, that do the work of managing cellular life.
  • The report forecasts the market size out for five years for a number of different market segments.

Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures

Retrieved on: 
Saturday, December 30, 2023
Professional Services, Finance, SomaLogic, Intellectual property, Labcorp, LAB, ISS, Acquisition, Transaction, LH, Pressure, Illumina, Security (finance)

As we quickly approach the January 4th Special Meeting of Shareholders, we want to reiterate our strong opposition to the Transaction because it (i.)

Key Points: 
  • As we quickly approach the January 4th Special Meeting of Shareholders, we want to reiterate our strong opposition to the Transaction because it (i.)
  • SomaLogic continues to dodge critical questions and instead simply repeats the same tired and weak points in support of the Proposed Merger.
  • As we have comprehensively articulated , SomaLogic has exciting opportunities to create value by terminating the Proposed Merger and pursuing alternative paths.
  • The Company should immediately activate the following simple five-point plan:
    Shareholders should not accept what is clearly a flawed and value-destructive deal.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 – (NASDAQ: ILMN)

Retrieved on: 
Thursday, December 14, 2023
NEXT, Fraud, ILMN, GRAIL, Illumina, Icahn, Security (finance)

DEADLINE: January 9, 2024 Shareholders should not delay in registering for this class action.

Key Points: 
  • DEADLINE: January 9, 2024 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is January 9, 2024.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 – (NASDAQ: ILMN)

Retrieved on: 
Monday, December 11, 2023
NEXT, Fraud, ILMN, GRAIL, Illumina, Icahn, Security (finance)

DEADLINE: January 9, 2024 Shareholders should not delay in registering for this class action.

Key Points: 
  • DEADLINE: January 9, 2024 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is January 9, 2024.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 – (NASDAQ: ILMN)

Retrieved on: 
Thursday, November 30, 2023
NEXT, Fraud, ILMN, GRAIL, Illumina, Icahn, Security (finance)

DEADLINE: January 9, 2024 Shareholders should not delay in registering for this class action.

Key Points: 
  • DEADLINE: January 9, 2024 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is January 9, 2024.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 – (NASDAQ: ILMN)

Retrieved on: 
Monday, November 27, 2023
NEXT, Fraud, ILMN, GRAIL, Illumina, Icahn, Security (finance)

DEADLINE: January 9, 2024 Shareholders should not delay in registering for this class action.

Key Points: 
  • DEADLINE: January 9, 2024 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is January 9, 2024.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)

Retrieved on: 
Monday, November 20, 2023
Defendant, Suite, Acquisition, GRAIL, Complaint, Illumina, Inc., GPM, Icahn, Court, News, Medical device, Accounting, Cryptocurrency, Reuters, Illumina

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Illumina securities during the Class Period, you may move the Court no later than January 9, 2024 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. (ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Monday, November 20, 2023
Telephone, GRAIL, LLP, CASE, Czarnik v. Illumina Inc., Icahn, CLASS, NEXT, Court, COST, Illumina

NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Illumina, Inc. ("Illumina" or the "Company") (NASDAQ: ILMN) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Illumina, Inc. ("Illumina" or the "Company") (NASDAQ: ILMN) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Illumina investors who were adversely affected by alleged securities fraud between May 1, 2023 and October 16, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    ILMN investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ILMN

Retrieved on: 
Sunday, November 19, 2023
Titan, Advertising, Czarnik v. Illumina Inc., Class, I-Space (Chinese company), Court, Tobacco, Insurance, Illumina

WHAT TO DO NEXT: To join the Illumina class action, go to https://rosenlegal.com/submit-form/?case_id=20435 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Illumina class action, go to https://rosenlegal.com/submit-form/?case_id=20435 or call Phillip Kim, Esq.
  • toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ILLUMINA ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Illumina To Contact Him Directly To Discuss Their Options

Retrieved on: 
Sunday, November 19, 2023
Acquisition, GRAIL, Advertising, LLP, Complaint, Illumina, Inc., Woman, Icahn, Court, News, Cryptocurrency, Reuters, Illumina

NEW YORK, Nov. 19, 2023 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN) and reminds investors of the January 9, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points: 
  • If you purchased or acquired securities in Illumina between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
  • Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • On this news, the Company's stock price fell $4.64, or 2.5%, to close at $180.48 per share on August 11, 2023.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Illumina’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.